Fundraising Fox
Leapfrog Bio
Founded 2019 · 13 employees on LinkedIn · 1 known investors
Find your way into Leapfrog Bio
Sign up to find every way you can get introduced to Leapfrog Bio
- Your email: who you already know at Leapfrog Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Leapfrog Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Leapfrog Bio is an oncology therapeutics company that uses its Precision PGx Platform to identify and develop targeted cancer treatments, focusing on patients with loss-of-function mutations through synthetic lethality and pharmacogenomic screening.
Founders & leadership
Leapfrog Bio was founded in 2019 by Tomas Babak.
Investors · 1
Two Bear Capitallisted by Two Bear CapitalWhitefish · $3M – $10M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Leapfrog Bio do?
- Leapfrog Bio is an oncology therapeutics company that uses its Precision PGx Platform to identify and develop targeted cancer treatments, focusing on patients with loss-of-function mutations through synthetic lethality and pharmacogenomic screening.
- Who founded Leapfrog Bio?
- Leapfrog Bio was founded by Tomas Babak in 2019.
- Who are Leapfrog Bio's investors?
- Leapfrog Bio's investors include Two Bear Capital.